Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
admission, AMP, appraisal, approach, auction, beneficiary, Big, Biographical, book, BPs, Callable, candidate, capped, ceiling, cessation, character, CIA, clause, CMS, Coast, complimentary, compound, concession, Creditor, crime, declaratory, deconsolidated, deconsolidation, Deficit, ElevessTM, energy, expend, expiry, FCP, FDAMA, foremost, formation, formula, fraudulent, fuel, Guard, Hepatic, hyperion, hypothetical, IMPAX, implantation, impracticable, improper, indeterminate, interval, Israeli, joint, Mentor, misclassified, noncontrolling, Nonrefundable, notwithstanding, occupy, optionee, outpatient, owner, Paragraph, PERLANE®are, preclude, procurement, promptly, proving, quoted, radio, ran, recalculation, reclassification, reconciliation, refrain, rejection, residual, RESTYLANE®and, retention, revance, Sculptra, secondary, strong, student, sublet, subprime, substantive, television, TRICARE, unclear, unlawful, unregistered, unsalable, unwilling, upper, VA, vacate, venture, VHCA
Removed:
acute, asthma, buying, cefdinir, Cephalexin, children, covenant, desoximetasone, discovery, ear, eradication, erythromycin, Excluding, extinguishment, HCI, head, incremental, lice, LUSTRA, malathion, middle, optional, OVIDE, Patheon, pathogen, pediculicide, pretax, PRIMSOL, Puerto, Rarely, rico, SCT, shampoo, suspension, taro, TOPICORT, trimethoprim, uncomplicated, vote
Filing tables
Filing exhibits
Related press release
Medicis Pharmaceutical similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statement (Form S-8 Nos. 33-45573, 33-88590, 33-311419, 33-333647, 333-81647, 333-101467, 333-126785, 333-135675 and 333-147705), and in the Registration Statements (Form S-3 No. 333-97207 and Form S-4 No. 333-107089) of Medicis Pharmaceutical Corporation of our reports dated February 26, 2008, with respect to the consolidated financial statements and schedule of Medicis Pharmaceutical Corporation and the effectiveness of internal control over financial reporting of Medicis Pharmaceutical Corporation, included in its Annual Report (Form 10-K) for the year ended December 31, 2007.
/s/ Ernst & Young LLP | ||||
Phoenix, Arizona
February 26, 2008
February 26, 2008